News
Biotechnology
30 July 2024 The global market for biotech active pharmaceutical ingredient (API) manufacturing services is poised for significant growth, according to an analysis from Transparency Market Research (TMR).
Today's issue
Refine Search
Pharmaceutical
Major pharmaceutical multinationals are looking to collaborate with Indian drug firms, leveraging their cost-efficient manufacturing capabilities, robust supply chains, and innovative research potential. 31 July 2024
Generics
Shares in Israeli drugmaker Teva Pharmaceutical Industries closed 4% higher following Wednesday’s trading in Tel Aviv. 31 July 2024
Biotechnology
Tigermed (SZ: 300347), a global clinical research solution provider, has completed a move to boost capabilities in Japan and beyond, with the acquisition of the contract research organization (CRO) Medical Edge. 31 July 2024
Biotechnology
Chinese biotech company LTZ Therapeutics has announced the completion of its series A financing round, raising over $20 million. 31 July 2024
Pharmaceutical
The Russian government will be ready to significantly increase state procurements of drugs against hepatitis C in case of reduction price for them both by global drugmakers and Russian pharmaceutical companies. 31 July 2024
Biotechnology
The US Food and Drug Administration (FDA) has approved a new indication for Darzalex Faspro, (daratumumab and hyaluronidase-fih) from US healthcare giant Johnson & Johnson. 31 July 2024
Pharmaceutical
Shares in UK pharma major GSK were 2% lower in London’s early afternoon trading on Wednesday. 31 July 2024
Pharmaceutical
Takeda today announced earnings results for the first quarter of fiscal year 2024 (period ended June 30, 2024). 31 July 2024
Pharmaceutical
Lundbeck announced it has been agreed with Takeda Pharmaceutical to modify the current collaboration in the USA. 31 July 2024
Biotechnology
Japanese drugmaker Chugai has signed a license agreement with Swiss pharma giant Roche for inavolisib. 31 July 2024
Pharmaceutical
Swiss pharma giant Roche is wasting no time in catching up with obesity frontrunners Novo Nordisk and Eli Lilly. 31 July 2024
Pharmaceutical
The US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for suzetrigine (VX-548). 31 July 2024
Pharmaceutical
The potential benefits for GLP-1 agonists appear unlimited, with new data at a leading Alzheimer’s conference suggesting a possible benefit for people taking an earlier generation option from Novo Nordisk (NOV: N). 31 July 2024
Biotechnology
Eisai (Tokyo: 4523) and Biogen (Nasdaq: BIIB) have shared new findings on Leqembi (lecanemab), the star of the show at the Alzheimer’s Association International Conference (AAIC) 2024. 31 July 2024
Biotechnology
Osaka-based Ono Pharmaceutical (TYO: 4502) has added a new collab to a growing list of deals made in 2024, agreeing to work with Systasy Bioscience. 31 July 2024
Biotechnology
MacroGenics yesterday announced the achievement of $100 million in milestones from Incyte Corp . 31 July 2024
Pharmaceutical
US pharma giant Pfizer has reported its first quarter of sales growth since COVID-19 revenue peaked in late 2022. 30 July 2024
Pharmaceutical
Shares in Merck & Co were more than 10% lower during Tuesday’s early trading in New York after the US pharma giant announced its second-quarter financial results and latest guidance for 2024. 30 July 2024
Biotechnology
Imunon has released data from the Phase II OVATION 2 study of its interleukin-12 (IL-12) immunotherapy called IMNN-001 in patients with advanced ovarian cancer. 30 July 2024
Pharmaceutical
As part of its regular benchmarking exercise, Swissmedic has concluded that other major medicines regulators, notably in Europe and the USA, are able to process regulatory submissions in less time. 30 July 2024
All news
Pharmaceutical
Major pharmaceutical multinationals are looking to collaborate with Indian drug firms, leveraging their cost-efficient manufacturing capabilities, robust supply chains, and innovative research potential. 31 July 2024
Generics
Shares in Israeli drugmaker Teva Pharmaceutical Industries closed 4% higher following Wednesday’s trading in Tel Aviv. 31 July 2024
Biotechnology
Tigermed (SZ: 300347), a global clinical research solution provider, has completed a move to boost capabilities in Japan and beyond, with the acquisition of the contract research organization (CRO) Medical Edge. 31 July 2024
Biotechnology
Chinese biotech company LTZ Therapeutics has announced the completion of its series A financing round, raising over $20 million. 31 July 2024
Pharmaceutical
The Russian government will be ready to significantly increase state procurements of drugs against hepatitis C in case of reduction price for them both by global drugmakers and Russian pharmaceutical companies. 31 July 2024
Biotechnology
The US Food and Drug Administration (FDA) has approved a new indication for Darzalex Faspro, (daratumumab and hyaluronidase-fih) from US healthcare giant Johnson & Johnson. 31 July 2024
Pharmaceutical
Shares in UK pharma major GSK were 2% lower in London’s early afternoon trading on Wednesday. 31 July 2024
Pharmaceutical
Takeda today announced earnings results for the first quarter of fiscal year 2024 (period ended June 30, 2024). 31 July 2024
Pharmaceutical
Lundbeck announced it has been agreed with Takeda Pharmaceutical to modify the current collaboration in the USA. 31 July 2024
Biotechnology
Japanese drugmaker Chugai has signed a license agreement with Swiss pharma giant Roche for inavolisib. 31 July 2024
Pharmaceutical
Swiss pharma giant Roche is wasting no time in catching up with obesity frontrunners Novo Nordisk and Eli Lilly. 31 July 2024
Pharmaceutical
The US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for suzetrigine (VX-548). 31 July 2024
Pharmaceutical
The potential benefits for GLP-1 agonists appear unlimited, with new data at a leading Alzheimer’s conference suggesting a possible benefit for people taking an earlier generation option from Novo Nordisk (NOV: N). 31 July 2024
Biotechnology
Eisai (Tokyo: 4523) and Biogen (Nasdaq: BIIB) have shared new findings on Leqembi (lecanemab), the star of the show at the Alzheimer’s Association International Conference (AAIC) 2024. 31 July 2024
Biotechnology
Osaka-based Ono Pharmaceutical (TYO: 4502) has added a new collab to a growing list of deals made in 2024, agreeing to work with Systasy Bioscience. 31 July 2024
Biotechnology
MacroGenics yesterday announced the achievement of $100 million in milestones from Incyte Corp . 31 July 2024
Pharmaceutical
US pharma giant Pfizer has reported its first quarter of sales growth since COVID-19 revenue peaked in late 2022. 30 July 2024
Pharmaceutical
Shares in Merck & Co were more than 10% lower during Tuesday’s early trading in New York after the US pharma giant announced its second-quarter financial results and latest guidance for 2024. 30 July 2024
Biotechnology
Imunon has released data from the Phase II OVATION 2 study of its interleukin-12 (IL-12) immunotherapy called IMNN-001 in patients with advanced ovarian cancer. 30 July 2024
Pharmaceutical
As part of its regular benchmarking exercise, Swissmedic has concluded that other major medicines regulators, notably in Europe and the USA, are able to process regulatory submissions in less time. 30 July 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze